Submission for OMB Review; 30-day Comment Request: Data and Specimen Hub (DASH) (Eunice Kennedy Shriver National Institute of Child Health and Human Development), 55729-55730 [2018-24313]
Download as PDF
<![CDATA[
Federal Register / Vol. 83, No. 216 / Wednesday, November 7, 2018 / Notices
guidance is to assist sponsors in the
clinical development of fixed
combination drug products for the
treatment of hypertension. The guidance
focuses on development of two-drug
combinations of previously approved
drug products. This guidance
incorporates the comments received for
and finalizes the draft guidance for
industry entitled ‘‘Hypertension:
Developing Fixed-Dose Combination
Drugs for Treatment’’ issued on January
26, 2018 (83 FR 3735). All the public
comments received on the draft
guidance have been considered, and the
guidance was revised as appropriate
primarily for editorial changes.
This guidance is being issued
consistent with FDA’s good guidance
practices regulation (21 CFR 10.115).
The guidance represents the current
thinking of FDA on ‘‘Hypertension:
Developing Fixed-Combination Drug
Products for Treatment.’’ It does not
establish any rights for any person and
is not binding on FDA or the public.
You can use an alternative approach if
it satisfies the requirements of the
applicable statutes and regulations. This
guidance is not subject to Executive
Order 12866.
II. Paperwork Reduction Act of 1995
This guidance refers to previously
approved collections of information that
are subject to review by the Office of
Management and Budget (OMB) under
the Paperwork Reduction Act of 1995
(44 U.S.C. 3501–3520). The collections
of information in 21 CFR part 312 has
been approved under OMB control
number 0910–0014. The collection of
information in the guidance for industry
entitled ‘‘Hypertension Indication: Drug
Labeling for Cardiovascular Outcome
Claims’’ (available at https://
www.fda.gov/ucm/groups/fdagovpublic/@fdagov-drugs-gen/documents/
document/ucm075072.pdf) has been
approved under OMB control number
0910–0670.
amozie on DSK3GDR082PROD with NOTICES1
III. Electronic Access
Persons with access to the internet
may obtain the guidance at either
https://www.fda.gov/Drugs/Guidance
ComplianceRegulatoryInformation/
Guidances/default.htm or https://
www.regulations.gov.
Dated: November 1, 2018.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2018–24315 Filed 11–6–18; 8:45 am]
BILLING CODE 4164–01–P
VerDate Sep<11>2014
17:46 Nov 06, 2018
Jkt 247001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Institute on
Aging Special Emphasis Panel,
November 19, 2018, 8:30 a.m. to
November 19, 2018, 4:00 p.m., National
Institute on Aging, Gateway Building,
7201 Wisconsin Avenue, Suite 2W200,
Bethesda, MD 20892 which was
published in the Federal Register on
October 30, 2018, 83 FR 54605.
The meeting notice is amended to
change the meeting location from the
National Institute on Aging, Gateway
Building, 7201 Wisconsin Avenue, Suite
2W200, Bethesda, MD 20892 to
Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814. The meeting
is closed to the public.
Dated: November 1, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–24293 Filed 11–6–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-day
Comment Request: Data and Specimen
Hub (DASH) (Eunice Kennedy Shriver
National Institute of Child Health and
Human Development)
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30-days of the date of this
publication.
SUMMARY:
Written comments and/or
suggestions regarding the item(s)
contained in this notice, especially
regarding the estimated public burden
and associated response time, should be
directed to the: Office of Management
and Budget, Office of Regulatory Affairs,
OIRA_submission@omb.eop.gov or by
ADDRESSES:
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
55729
fax to 202–395–6974, Attention: Desk
Officer for NIH.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Rohan Hazra,
M.D., Eunice Kennedy Shriver National
Institute of Child Health and Human
Development (NICHD), National
Institutes of Health, 6710B Rockledge
Drive, Room 2113, Bethesda, MD 20817,
or call non-toll-free number (301)–435–
6868 or Email your request, including
your address to: rohan.hazra@nih.gov.
SUPPLEMENTARY INFORMATION: This
proposed information collection was
previously published in the Federal
Register on April 27, 2018, page 18576
(Vol 83) and allowed 60 days for public
comment. No public comments were
received. The purpose of this notice is
to allow an additional 30 days for public
comment.
The Eunice Kennedy Shriver National
Institute of Child Health and Human
Development (NICHD), National
Institutes of Health, may not conduct or
sponsor, and the respondent is not
required to respond to, an information
collection that has been extended,
revised, or implemented on or after
October 1, 1995, unless it displays a
currently valid OMB control number.
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below.
Proposed Collection: Data and
Specimen Hub (DASH) 0925–0774 exp.
date 6/30/19—REVISION; Eunice
Kennedy Shriver National Institute of
Child Health and Human Development
(NICHD), National Institutes of Health
(NIH).
Need and Use of Information
Collection:
This is a request to revise the
previously approved submission to add
the collection of additional information
from Users who will request
biospecimens, submit the Institutional
Certification for data/biospecimen
inventory, and submit DASH data/
biospecimen Annual Progress Report for
the NICHD Data and Specimen Hub
(DASH). DASH has been established by
NICHD as a data sharing mechanism for
biomedical research investigators. It
serves as a centralized resource for
investigators to store and access
deidentified study data and
biospecimen inventories—a list of
biospecimens available at the NICHD
E:\FR\FM\07NON1.SGM
07NON1
55730
Federal Register / Vol. 83, No. 216 / Wednesday, November 7, 2018 / Notices
Biorepository—from studies funded by
NICHD. The potential for public benefit
to be achieved through sharing study
data and/or biospecimen inventories for
secondary analysis is significant. NICHD
DASH supports NICHD’s mission to
ensure that every person is born healthy
and wanted, that women suffer no
harmful effects from reproductive
processes, and that all children have the
chance to achieve their full potential for
healthy and productive lives, free from
disease or disability, and to ensure the
health, productivity, independence, and
well-being of all people through optimal
rehabilitation. Study data and
biospecimen sharing and reuse will
promote testing of new hypotheses from
data already collected, facilitate
transdisciplinary collaboration,
accelerate scientific findings and enable
NICHD to maximize the return on its
investments in research.
Anyone can access NICHD DASH to
browse and view descriptive
information about the studies and study
data archived in NICHD DASH without
creating an account. Users who wish to
submit or request research data and/or
biospecimen inventories must register
for an account.
Information will be collected from
those wishing to create an account,
sufficient to identify them as unique
Users. Those submitting or requesting
data and/or biospecimen inventories
will be required to provide additional
supporting information to ensure proper
use and security of NICHD DASH study
data and biospecimen inventories. The
information collected is limited to the
essential data required to ensure the
management of Users in NICHD DASH
is efficient and the sharing of data and
biospecimens among investigators is
effective. The primary uses of the
information collected from Users by
NICHD will be to:
• Communicate with the Users with
regards to their data submission, data
requests and biospecimen requests
• Monitor data submissions, data
requests and biospecimen requests
• Notify interested recipients of updates
to data and biospecimen inventories
stored in NICHD DASH
• Help NICHD understand the use of
NICHD DASH study data and
biospecimen inventories by the
research community
All the data collected from use of
NICHD DASH except for information
provided in the annual progress reports
are for the purposes of internal
administrative management of NICHD
DASH. Information gathered through
the annual progress reports may be used
in publications describing performance
of the DASH system.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
204.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form
Average time
per response
(in hours)
Total annual
burden hour
User Registration .............................................................................................
Data Submission and Biospecimen Inventory Submissions ...........................
Data Request ...................................................................................................
Biospecimen Request ......................................................................................
Data Use Annual Progress Report ..................................................................
Biospecimen Use Annual Progress Report .....................................................
Institutional Certification Template ..................................................................
200
36
60
36
60
36
36
1
1
1
1
1
1
1
5/60
2
1
1
10/60
10/60
5/60
17
72
60
36
10
6
3
Total ..........................................................................................................
200
200
........................
204
Dated: November 1, 2018.
Jennifer M. Guimond,
Project Clearance Liaison, Eunice Kennedy
Shriver National Institute of Child Health and
Human Development, National Institutes of
Health.
[FR Doc. 2018–24313 Filed 11–6–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
amozie on DSK3GDR082PROD with NOTICES1
Number of
responses
per
respondent
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
VerDate Sep<11>2014
17:46 Nov 06, 2018
Jkt 247001
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Primate Center for Gene Therapy.
Date: November 30, 2018.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6701
Rockledge Drive, Room 7180, Bethesda, MD
20892 (Telephone Conference Call).
Contact Person: Tony L Creazzo, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA National Heart, Lung, and
Blood Institute, National Institutes of Health,
6701 Rockledge Drive, Room 7180, Bethesda,
MD 20892–7924, 301–827–7913.
PO 00000
Frm 00043
Fmt 4703
Sfmt 9990
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: November 1, 2018.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–24294 Filed 11–6–18; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\07NON1.SGM
07NON1
]]>Agencies
[Federal Register Volume 83, Number 216 (Wednesday, November 7, 2018)]
[Notices]
[Pages 55729-55730]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-24313]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-day Comment Request: Data and
Specimen Hub (DASH) (Eunice Kennedy Shriver National Institute of Child
Health and Human Development)
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has submitted to the Office of
Management and Budget (OMB) a request for review and approval of the
information collection listed below.
DATES: Comments regarding this information collection are best assured
of having their full effect if received within 30-days of the date of
this publication.
ADDRESSES: Written comments and/or suggestions regarding the item(s)
contained in this notice, especially regarding the estimated public
burden and associated response time, should be directed to the: Office
of Management and Budget, Office of Regulatory Affairs,
[email protected] or by fax to 202-395-6974, Attention: Desk
Officer for NIH.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the data collection plans and
instruments, contact: Rohan Hazra, M.D., Eunice Kennedy Shriver
National Institute of Child Health and Human Development (NICHD),
National Institutes of Health, 6710B Rockledge Drive, Room 2113,
Bethesda, MD 20817, or call non-toll-free number (301)-435-6868 or
Email your request, including your address to: [email protected].
SUPPLEMENTARY INFORMATION: This proposed information collection was
previously published in the Federal Register on April 27, 2018, page
18576 (Vol 83) and allowed 60 days for public comment. No public
comments were received. The purpose of this notice is to allow an
additional 30 days for public comment.
The Eunice Kennedy Shriver National Institute of Child Health and
Human Development (NICHD), National Institutes of Health, may not
conduct or sponsor, and the respondent is not required to respond to,
an information collection that has been extended, revised, or
implemented on or after October 1, 1995, unless it displays a currently
valid OMB control number.
In compliance with Section 3507(a)(1)(D) of the Paperwork Reduction
Act of 1995, the National Institutes of Health (NIH) has submitted to
the Office of Management and Budget (OMB) a request for review and
approval of the information collection listed below.
Proposed Collection: Data and Specimen Hub (DASH) 0925-0774 exp.
date 6/30/19--REVISION; Eunice Kennedy Shriver National Institute of
Child Health and Human Development (NICHD), National Institutes of
Health (NIH).
Need and Use of Information Collection:
This is a request to revise the previously approved submission to
add the collection of additional information from Users who will
request biospecimens, submit the Institutional Certification for data/
biospecimen inventory, and submit DASH data/biospecimen Annual Progress
Report for the NICHD Data and Specimen Hub (DASH). DASH has been
established by NICHD as a data sharing mechanism for biomedical
research investigators. It serves as a centralized resource for
investigators to store and access deidentified study data and
biospecimen inventories--a list of biospecimens available at the NICHD
[[Page 55730]]
Biorepository--from studies funded by NICHD. The potential for public
benefit to be achieved through sharing study data and/or biospecimen
inventories for secondary analysis is significant. NICHD DASH supports
NICHD's mission to ensure that every person is born healthy and wanted,
that women suffer no harmful effects from reproductive processes, and
that all children have the chance to achieve their full potential for
healthy and productive lives, free from disease or disability, and to
ensure the health, productivity, independence, and well-being of all
people through optimal rehabilitation. Study data and biospecimen
sharing and reuse will promote testing of new hypotheses from data
already collected, facilitate transdisciplinary collaboration,
accelerate scientific findings and enable NICHD to maximize the return
on its investments in research.
Anyone can access NICHD DASH to browse and view descriptive
information about the studies and study data archived in NICHD DASH
without creating an account. Users who wish to submit or request
research data and/or biospecimen inventories must register for an
account.
Information will be collected from those wishing to create an
account, sufficient to identify them as unique Users. Those submitting
or requesting data and/or biospecimen inventories will be required to
provide additional supporting information to ensure proper use and
security of NICHD DASH study data and biospecimen inventories. The
information collected is limited to the essential data required to
ensure the management of Users in NICHD DASH is efficient and the
sharing of data and biospecimens among investigators is effective. The
primary uses of the information collected from Users by NICHD will be
to:
Communicate with the Users with regards to their data
submission, data requests and biospecimen requests
Monitor data submissions, data requests and biospecimen
requests
Notify interested recipients of updates to data and
biospecimen inventories stored in NICHD DASH
Help NICHD understand the use of NICHD DASH study data and
biospecimen inventories by the research community
All the data collected from use of NICHD DASH except for
information provided in the annual progress reports are for the
purposes of internal administrative management of NICHD DASH.
Information gathered through the annual progress reports may be used in
publications describing performance of the DASH system.
OMB approval is requested for 3 years. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 204.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average time
Form Number of responses per per response Total annual
respondents respondent (in hours) burden hour
----------------------------------------------------------------------------------------------------------------
User Registration............................... 200 1 5/60 17
Data Submission and Biospecimen Inventory 36 1 2 72
Submissions....................................
Data Request.................................... 60 1 1 60
Biospecimen Request............................. 36 1 1 36
Data Use Annual Progress Report................. 60 1 10/60 10
Biospecimen Use Annual Progress Report.......... 36 1 10/60 6
Institutional Certification Template............ 36 1 5/60 3
---------------------------------------------------------------
Total....................................... 200 200 .............. 204
----------------------------------------------------------------------------------------------------------------
Dated: November 1, 2018.
Jennifer M. Guimond,
Project Clearance Liaison, Eunice Kennedy Shriver National Institute of
Child Health and Human Development, National Institutes of Health.
[FR Doc. 2018-24313 Filed 11-6-18; 8:45 am]
BILLING CODE 4140-01-P
